TABLE 4.
Significant metabolic pathways involved in the five neurodegenerative diseases.
| Traits | Metabolites pathway | Involved metabolites | P-value | Database |
| AD | Urea cycle | Urea, L-Glutamine | 0.0364 | SMPDB |
| AD | Arginine biosynthesis | Urea, L-Glutamine | 0.0040 | KEGG |
| AD | Purine metabolism | Guanosine, L-Glutamine | 0.0093 | KEGG |
| AD | D-Glutamine and D-glutamate metabolism | L-Glutamine | 0.0421 | KEGG |
| ALS | Phenylalanine, tyrosine and tryptophan biosynthesis | L-Phenylalanine | 0.0459 | KEGG |
| FTD | Carnitine synthesis | L-Lysine, Oxoglutaric acid | 0.0441 | SMPDB |
| MS | Phenylalanine, tyrosine and tryptophan biosynthesis | L-Tyrosine | 0.0232 | KEGG |
AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; FTD, frontotemporal dementia; MS, multiple sclerosis; KEGG, Kyoto encyclopedia of genes and genomes; SMPDB, small molecule pathway database.